Post-effective amendment to a registration statement that is not immediately effective upon filing

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2021
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 02, 2021
Dec. 31, 2022
Financial Designation, Predecessor and Successor [Fixed List] Successor           Predecessor Successor
OPERATING REVENUE:                
TOTAL OPERATING REVENUE   $ 58,762 $ 302,077     $ 273,544 $ 578,602 $ 1,049,471
OPERATING EXPENSE:                
Medical expense   66,877 285,570     265,821 592,465 1,057,224
Premium deficiency reserve   26,277 5,140     (1,325) 11,559 (11,461)
Corporate, general and administrative expense   16,983 37,643     38,599 100,243 157,284
Sales and marketing expense   364 1,001     865 1,818 5,096
Depreciation and amortization   7,149 21,540     21,752 1,575 87,289
Goodwill impairment   0   $ 463,500 $ 851,500     1,314,952
TOTAL OPERATING EXPENSE   117,650 350,894     325,712 707,660 2,610,384
OPERATING LOSS   (58,888) (48,817)     (52,168) (129,058) (1,560,913)
OTHER INCOME (EXPENSE):                
Interest expense, net   (851) (4,086)     (2,755) (9,824) (11,404)
Mark-to-market of stock warrants   2,272 649     (5,861) (7,665) 9,865
Other   (471) 96     (6) 147 2,757
TOTAL OTHER EXPENSE   950 (3,341)     (8,622) (17,342) 1,218
LOSS BEFORE INCOME TAXES   (57,938) (52,158)     (60,790) (146,400) (1,559,695)
PROVISION FOR INCOME TAXES     (290)         (1,862)
NET LOSS   (57,938) (52,448)     (60,790) (146,400) (1,561,557)
LESS: NET LOSS ATTRIBUTABLE TO REDEEMABLE NON-CONTROLLING INTERESTS   (47,857) (43,249)     (50,213)   (1,291,430)
NET LOSS ATTRIBUTABLE TO CONTROLLING INTERESTS   $ (10,081) $ (9,199)     $ (10,577) (146,400) $ (270,127)
Basic (in dollars per share)   $ (0.24) $ (0.22)     $ (0.25)   $ (6.50)
Diluted (in dollars per share)   $ (0.24) $ (0.22)     $ (0.25)   $ (6.50)
Basic (in shares)   41,579 41,579,000     41,579,000   41,579
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (DILUTED)   41,579 41,579,000     41,579,000   41,579
Capitated revenue                
OPERATING REVENUE:                
TOTAL OPERATING REVENUE   $ 57,224 $ 298,704     $ 269,685 567,735 $ 1,034,800
Other patient service revenue                
OPERATING REVENUE:                
TOTAL OPERATING REVENUE   $ 1,538 $ 3,373     $ 3,859 $ 10,867 $ 14,671